SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VaxGen Inc.-The 1st AIDS Vaccine in Phase 3 HumanTrials
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: wiz who wrote (67)7/7/1999 4:53:00 PM
From: glen   of 250
 
Almost all news pertaining to new drug developments in AIDS Research pertains to drugs used to treat those already infected. At this time, there is no known cure for AIDS/HIV and the drugs on the market are used to prolong the lives of those infected. And, these drugs regimens are very expensive.

The target for a successful AIDS Vaccine is the rest of the world's population, which is not infected, and is potentially a huge market. While there have been many drugs that have come to market which can be evaluated and written up, AIDSVAX is the only vaccine to ever be approved by the FDA to enter into Phase III Human Clinical Trials. It is difficult to write about its potential when only projections can be made. Scientifically, and politically, the development of a successful AIDS vaccine has been and is, controversial. There are many supporters and detractors. The whys of this can perhaps be better explained by GPS.

Nevertheless, the investment potential in terms of the risk/reward of the successful completion of this vaccine, is staggering. The lack of publicity and hype can be viewed as an investment opportunity for those who believe in the eventual approval of AIDSVAX by the FDA. I, for one, believe believe those chances to be very high.

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News